Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: 18F Fluoroestradiol Radiopharmaceutical with PET/CT
Sponsor: Zionexa
Collaborators: Simbec-Orion Group|Medpace, Inc.|GE Healthcare